Joel Moss

Q: What Schools Are Affiliated With Joel Moss

Joel Moss is affiliated with the following schools: Sun Yat-sen University, Chiba University, Nagasaki University, University of Missouri, Baylor College of Medicine, University of Florence, Uniformed Services University of the Health Sciences, Duke University

Joel Moss's AcademicInfluence.com Rankings

Joel Moss

Philosophy

#3354

World Rank

#5436

Historical Rank

Logic

#1104

World Rank

#1753

Historical Rank

philosophy Degrees

Joel Moss

Biology

#4171

World Rank

#6261

Historical Rank

Molecular Biology

#306

World Rank

#311

Historical Rank

Biochemistry

#425

World Rank

#505

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Joel Moss's Degrees

Doctorate Medicine Stanford University

Why Is Joel Moss Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Joel Moss's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. (2000) (567)
Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators (2013) (558)
Efficacy and safety of sirolimus in lymphangioleiomyomatosis. (2011) (523)
Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. (2000) (517)
Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. (2008) (376)
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. (2006) (372)
Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. (1985) (366)
Molecules in the ARF Orbit* (1998) (356)
Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin (1998) (356)
Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. (2000) (334)
Structure and Function of ARF Proteins: Activators of Cholera Toxin and Critical Components of Intracellular Vesicular Transport Processes (*) (1995) (320)
Activation of adenylate cyclase by choleragen. (1979) (305)
Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. (1999) (303)
beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. (1998) (297)
Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. (1977) (292)
Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. (2001) (282)
Identification and Characterization of a Mammalian 39-kDa Poly(ADP-ribose) Glycohydrolase* (2006) (268)
Encyclopedia of Dietary Supplements (2010) (267)
Adp-Ribosylating Toxins and G Proteins: Insights into Signal Transduction (1990) (264)
ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins. (1988) (243)
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers (2013) (239)
Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. (1989) (239)
Activation of rat brain phospholipase D by ADP-ribosylation factors 1,5, and 6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes. (1994) (233)
Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase. (1993) (228)
Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness. (1976) (211)
Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. (2004) (196)
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management. (2016) (196)
Acetyl coenzyme A carboxylase. (1974) (196)
Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species (195)
Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. (2000) (195)
The biotin-dependent enzymes. (1971) (187)
β-Arrestin-mediated ADP-ribosylation Factor 6 Activation and β2-Adrenergic Receptor Endocytosis* (2001) (181)
Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells. (1991) (179)
Activation of Helicobacter pylori VacA Toxin by Alkaline or Acid Conditions Increases Its Binding to a 250-kDa Receptor Protein-tyrosine Phosphatase β* (1999) (172)
Mitogen-activated Protein Kinases Mediate Activator Protein-1-dependent Human Inducible Nitric-oxide Synthase Promoter Activation* (2001) (172)
ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. (1984) (171)
Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. (2011) (170)
Acetyl coenzyme A carboxylase system of Escherichia coli. Purification and properties of the biotin carboxylase, carboxyltransferase, and carboxyl carrier protein components. (1974) (169)
Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. (1998) (167)
Bacterial toxins and virulence factors in disease (1995) (163)
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. (2004) (162)
Salmonella enteritidis FliC (Flagella Filament Protein) Induces Human β-Defensin-2 mRNA Production by Caco-2 Cells* (2001) (158)
Effect of cyclic AMP on the intracellular degradation of newly synthesized collagen. (1980) (158)
Molecular characterization of NAD:arginine ADP-ribosyltransferase from rabbit skeletal muscle. (1992) (156)
Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor. (1997) (156)
GIT Proteins, A Novel Family of Phosphatidylinositol 3,4,5-Trisphosphate-stimulated GTPase-activating Proteins for ARF6* (2000) (156)
Purification and Cloning of a Brefeldin A-inhibited Guanine Nucleotide-exchange Protein for ADP-ribosylation Factors* (1999) (156)
Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain. (1996) (155)
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). (1997) (152)
Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm. (2012) (151)
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. (2013) (149)
Helicobacter pylori Vacuolating Cytotoxin Induces Activation of the Proapoptotic Proteins Bax and Bak, Leading to Cytochrome c Release and Cell Death, Independent of Vacuolation* (2006) (149)
Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis. (2000) (147)
Opportunities in Interventional and Diagnostic Imaging by Using High-performance Low-Field-Strength MRI. (2019) (146)
Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. (1991) (144)
Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase. (1976) (142)
Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells. (1983) (142)
Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells. (1993) (141)
Lymphangioleiomyomatosis: abdominopelvic CT and US findings. (2000) (141)
Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). (1983) (139)
Isolation and properties of an NAD- and guanidine-dependent ADP-ribosyltransferase from turkey erythrocytes. (1980) (134)
TRIM23 mediates virus-induced autophagy via activation of TBK1 (2017) (133)
Activation of adenylate cyclase by heat-labile Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that of choleragen. (1978) (133)
Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. (2000) (130)
Identification of antigens and antibodies specific for Pneumocystis carinii. (1988) (130)
ADP ribosylation of human neutrophil peptide-1 regulates its biological properties (2002) (125)
Lymphangioleiomyomatosis Diagnosis and Management: High‐Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline (2017) (124)
Rhodopsin-enhanced GTPase activity of the inhibitory GTP-binding protein of adenylate cyclase. (1984) (123)
Helicobacter pylori VacA-induced Inhibition of GSK3 through the PI3K/Akt Signaling Pathway* (2009) (123)
Interaction of choleragen with the oligosaccharide of ganglioside GM1: evidence for multiple oligosaccharide binding sites. (1978) (123)
Isolation of an avian erythrocyte protein possessing ADP-ribosyltransferase activity and capable of activating adenylate cyclase. (1978) (121)
ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress (2013) (121)
Association in normal human fibroblasts of elevated levels of adenosine 3':5'-monophosphate with a selective decrease in collagen production. (1978) (121)
Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex. (2000) (120)
Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. (2000) (120)
Alternative Splicing of Human Inducible Nitric-Oxide Synthase mRNA (1996) (117)
ARF-GEP100, a guanine nucleotide-exchange protein for ADP-ribosylation factor 6 (2001) (116)
Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis. (1999) (114)
Mechanism of action of choleragen. (1978) (112)
Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms (2009) (109)
Molecular and immunological characterization of ADP-ribosylarginine hydrolases. (1992) (109)
Expression, Characterization, and Mutagenesis of theYersinia pestis Murine Toxin, a Phospholipase D Superfamily Member* (1999) (109)
Low-density Lipoprotein Receptor-related Protein-1 (LRP1) Mediates Autophagy and Apoptosis Caused by Helicobacter pylori VacA* (2012) (108)
ADP-ribosylhydrolase 3 (ARH3), Not Poly(ADP-ribose) Glycohydrolase (PARG) Isoforms, Is Responsible for Degradation of Mitochondrial Matrix-associated Poly(ADP-ribose)* (2012) (108)
Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement. (2009) (106)
Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. (2001) (104)
Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor. (1997) (104)
Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features. (2007) (103)
The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases (2006) (101)
Helicobacter pylori VacA Activates the p38/Activating Transcription Factor 2-mediated Signal Pathway in AZ-521 Cells* (2004) (100)
Glyceraldehyde-3-phosphate Dehydrogenase Enhances Transcriptional Activity of Androgen Receptor in Prostate Cancer Cells* (2007) (99)
Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain. (1988) (97)
Binding sites of the 9- and 14-kilodalton heterodimeric protein subunit of the signal recognition particle (SRP) are contained exclusively in the Alu domain of SRP RNA and contain a sequence motif that is conserved in evolution. (1991) (96)
Similarities in Function and Gene Structure of Cytohesin-4 and Cytohesin-1, Guanine Nucleotide-exchange Proteins for ADP-ribosylation Factors* (2000) (96)
Brefeldin A-inhibited guanine nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian ADP ribosylation factors. (1998) (95)
Molecular and catalytic properties of cytosolic acetoacetyl coenzyme A thiolase from avian liver. (1973) (94)
Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. (2009) (93)
Characterization of an ADP-ribosylation Factor-like 1 Protein inSaccharomyces cerevisiae * (1997) (93)
Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1 (2008) (92)
ARL4D recruits cytohesin-2/ARNO to modulate actin remodeling. (2007) (91)
Protein-tyrosine Phosphatase α, RPTPα, Is a Helicobacter pylori VacA Receptor* (2003) (90)
Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi. (1993) (90)
Amino acid-specific ADP-ribosylation. (1983) (89)
Stimulation of Signal Transducer and Activator of Transcription-1 (STAT1)-dependent Gene Transcription by Lipopolysaccharide and Interferon-γ Is Regulated by Mammalian Target of Rapamycin* (2003) (89)
beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis. (2001) (88)
Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis. (2014) (88)
Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway. (2017) (87)
The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. (2010) (87)
Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase (2017) (87)
Different ARF Domains Are Required for the Activation of Cholera Toxin and Phospholipase D (*) (1995) (87)
ADP-ribosylation of transducin by pertussis toxin. (1985) (85)
Exogenous gangliosides enhance the interaction of fibronectin with ganglioside-deficient cells. (1983) (84)
Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization. (1998) (84)
Reversibility of arginine-specific mono(ADP-ribosyl)ation: identification in erythrocytes of an ADP-ribose-L-arginine cleavage enzyme. (1985) (83)
Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) (2003) (83)
Molecular Characterization of Helicobacter pylori VacA Induction of IL-8 in U937 Cells Reveals a Prominent Role for p38MAPK in Activating Transcription Factor-2, cAMP Response Element Binding Protein, and NF-κB Activation1 (2008) (82)
Molecular cloning, characterization, and expression of human ADP-ribosylation factors: two guanine nucleotide-dependent activators of cholera toxin. (1989) (82)
Enhancement of choleragen ADP-ribosyltransferase activities by guanyl nucleotides and a 19-kDa membrane protein. (1987) (81)
Glycosylphosphatidylinositol-anchored and Secretory Isoforms of Mono-ADP-ribosyltransferases* (1998) (81)
Lymphangioleiomyomatosis: what do we know and what are we looking for? (2011) (81)
Uptake and metabolism of gangliosides in transformed mouse fibroblasts. Relationship of ganglioside structure to choleragen response. (1976) (80)
Immunological and structural conservation of mammalian skeletal muscle glycosylphosphatidylinositol-linked ADP-ribosyltransferases. (1994) (80)
Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA. (2010) (79)
Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases. (1999) (78)
Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests. (2000) (77)
Regulation of Collagen Production by the β-Adrenergic System (1981) (76)
Identification in traditional herbal medications and confirmation by synthesis of factors that inhibit cholera toxin-induced fluid accumulation (2002) (76)
Morphologic Differentiation of HL-60 Cells Is Associated with Appearance of RPTPβ and Induction of Helicobacter pyloriVacA Sensitivity* (2000) (76)
Structural basis for the inhibitory effect of brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors. (1999) (75)
Mechanism of inhibition of transducin GTPase activity by fluoride and aluminum. (1985) (75)
Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis (2015) (75)
Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen. (1986) (75)
Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis. (2003) (74)
ADP-ribosyltransferases, an update on function and nomenclature (2021) (74)
Structural Diversity in the 5′-Untranslated Region of Cytokine-stimulated Human Inducible Nitric Oxide Synthase mRNA (*) (1995) (74)
Induction of human beta-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island. (1999) (74)
Stimulation of endogenous ADP-ribosylation by brefeldin A. (1994) (74)
Conservation of a Common Motif in Enzymes Catalyzing ADP-ribose Transfer (1995) (73)
GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin. (2006) (73)
Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex. (2014) (73)
Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha1-antitrypsin deficiency. (1999) (72)
Acetyl Coenzyme A Carboxylase: Filamentous Nature of the Animal Enzymes (1969) (72)
Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation. (1992) (72)
Receptors for bradykinin in intact cultured human fibroblasts. Identification and characterization by direct binding study. (1983) (72)
Differential Activities of Plant Polyphenols on the Binding and Internalization of Cholera Toxin in Vero Cells* (2005) (71)
Effects of guanyl nucleotides and rhodopsin on ADP-ribosylation of the inhibitory GTP-binding component of adenylate cyclase by pertussis toxin. (1984) (70)
Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study. (2007) (70)
Expression of NAD glycohydrolase activity by rat mammary adenocarcinoma cells transformed with rat T cell alloantigen RT6.2. (1994) (69)
Amino acid specific ADP-ribosylation: substrate specificity of an ADP-ribosylarginine hydrolase from turkey erythrocytes. (1986) (68)
Mechanism of action of cholera toxin on intact cells. Generation of A1 peptide and activation of adenylate cyclase. (1982) (68)
Amino acid-specific ADP-ribosylation. Evidence for two distinct NAD:arginine ADP-ribosyltransferases in turkey erythrocytes. (1983) (68)
Oral findings in 58 adults with tuberous sclerosis complex. (2007) (68)
Auto-ADP-ribosylation of Pseudomonas aeruginosaExoS* (2002) (66)
Guanine nucleotide-binding proteins in the intestinal parasite Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP-ribosylation factor. (1992) (65)
Modulation of collagen production by fibroblasts. Effects of chronic exposure to agonists that increase intracellular cyclic AMP. (1982) (65)
Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis. (2008) (65)
Protein-tyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. (2003) (64)
Deduced amino acid sequence of bovine retinal Go alpha: similarities to other guanine nucleotide-binding proteins. (1987) (63)
Escherichia coli heat-labile enterotoxin. Ganglioside specificity and ADP-ribosyltransferase activity. (1981) (63)
Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases. (2014) (63)
Amino acid-specific ADP-ribosylation. Sensitivity to hydroxylamine of [cysteine(ADP-ribose)]protein and [arginine(ADP-ribose)]protein linkages. (1985) (63)
Characterization of a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae. (1994) (62)
Enhanced Sensitivity to Cholera Toxin in ADP-Ribosylarginine Hydrolase-Deficient Mice (2007) (62)
Amino acid-specific ADP-ribosylation. Identification of an arginine-dependent ADP-ribosyltransferase in rat liver. (1981) (62)
Cloning and Characterization of a Novel Membrane-associated Lymphocyte NAD:Arginine ADP-ribosyltransferase* (1996) (62)
Lymphatics in Lung Disease (2008) (60)
Hydroxylamine-stable covalent linkage of myristic acid in G0 alpha, a guanine nucleotide-binding protein of bovine brain. (1987) (60)
Effect of Rho and ADP-ribosylation Factor GTPases on Phospholipase D Activity in Intact Human Adenocarcinoma A549 Cells* (1999) (60)
Gangliosides Act as Co-receptors for Salmonella enteritidis FliC and Promote FliC Induction of Human β-Defensin-2 Expression in Caco-2 Cells* (2004) (60)
Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. (1986) (60)
Association of brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) with recycling endosomes during transferrin uptake. (2006) (60)
Structure-activity analysis of the activation of pertussis toxin. (1987) (60)
Mono-ADP-ribosylation: a reversible posttranslational modification of proteins. (1996) (60)
Clustering of Helicobacter pylori VacA in Lipid Rafts, Mediated by Its Receptor, Receptor-Like Protein Tyrosine Phosphatase β, Is Required for Intoxication in AZ-521 Cells (2006) (60)
Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA. (1988) (59)
Endoplasmic Reticulum Stress Contributes to Helicobacter Pylori VacA-Induced Apoptosis (2013) (59)
ADP-ribosyltransferase-specific Modification of Human Neutrophil Peptide-1* (2006) (59)
Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis. (2012) (58)
Correction of the PNH defect by GPI-anchored protein transfer. (1998) (58)
Autoregulation of bradykinin receptors and bradykinin-induced prostacyclin formation in human fibroblasts. (1984) (57)
Modification of ganglioside GM1. Effect of lipid moiety on choleragen action. (1980) (57)
Recognition of Tuberous Sclerosis in Adult Women: Delayed Presentation With Life-Threatening Consequences (2011) (57)
NAD-dependent ADP-ribosylation of arginine and proteins by Escherichia coli heat-labile enterotoxin. (1979) (57)
Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis. (2010) (56)
STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activation. (2003) (56)
Substrate specificity and partial purification of a stereospecific NAD- and guanidine-dependent ADP-ribosyltransferase from avian erythrocytes. (1979) (56)
Lymphangioleiomyomatosis: correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis. (2002) (56)
The Brefeldin A-inhibited Guanine Nucleotide-exchange Protein, BIG2, Regulates the Constitutive Release of TNFR1 Exosome-like Vesicles* (2007) (56)
NIH conference. Cyclic nucleotides: mediators of bacterial toxin action in disease. (1984) (56)
Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma. (2015) (56)
TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis. (2007) (55)
Processing of ADP-ribosylated Integrin 7 in Skeletal Muscle Myotubes (*) (1995) (55)
On the mechanism of preadipocyte differentiation. Masking of poly(ADP-ribose) synthetase activity during differentiation of 3T3-L1 preadipocytes. (1981) (55)
Mechanism of cholera toxin activation by a guanine nucleotide-dependent 19 kDa protein. (1990) (54)
Subtilase cytotoxin, produced by Shiga‐toxigenic Escherichia coli, transiently inhibits protein synthesis of Vero cells via degradation of BiP and induces cell cycle arrest at G1 by downregulation of cyclin D1 (2008) (54)
Effects of brefeldin A and accessory proteins on association of ADP-ribosylation factors 1, 3, and 5 with Golgi. (1993) (54)
Brefeldin A Inhibited Activity of the Sec7 Domain of p200, a Mammalian Guanine Nucleotide-exchange Protein for ADP-ribosylation Factors* (1999) (54)
Guanine Nucleotide Exchange on ADP-ribosylation Factors Catalyzed by Cytohesin-1 and Its Sec7 Domain* (1998) (54)
Effects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity. (1993) (53)
Two Distinct Cytotoxic Activities of Subtilase Cytotoxin Produced by Shiga-Toxigenic Escherichia coli (2006) (52)
Acral lesions in tuberous sclerosis complex: insights into pathogenesis. (2010) (52)
Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor. (1999) (51)
Fluorescent gangliosides as probes for the retention and organization of fibronectin by ganglioside-deficient mouse cells (1985) (51)
Synthesis and uptake of gangliosides by choleragen-responsive human fibroblasts. (1977) (51)
Interaction of BIG2, a brefeldin A-inhibited guanine nucleotide-exchange protein, with exocyst protein Exo70. (2005) (51)
Modification of proteins by mono(ADP-ribosylation) in vivo. (1985) (50)
CT of sclerotic bone lesions: imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis. (2010) (50)
ARL4, an ARF-like Protein That Is Developmentally Regulated and Localized to Nuclei and Nucleoli* (2000) (50)
Cloning and site-directed mutagenesis of human ADP-ribosylarginine hydrolase. (1993) (50)
Mesenchymal–epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas (2008) (50)
Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis (2015) (49)
Modification of plasma membrane protein cysteine residues by ADP-ribose in vivo. (1990) (49)
Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies. (2010) (48)
Activation of Escherichia coli heat-labile enterotoxins by native and recombinant adenosine diphosphate-ribosylation factors, 20-kD guanine nucleotide-binding proteins. (1991) (48)
Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization. (2013) (48)
Uptake and metabolism of exogenous gangliosides by cultured cells: effect of choleragen on the turnover of GM1. (1983) (48)
ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis. (2011) (48)
The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15‐Year Prospective Longitudinal Analysis (2019) (48)
Effect of gangliosides and substrate analogues on the hydrolysis of nicotinamide adenine dinucleotide by choleragen. (1977) (48)
NAD glycohydrolase and ADP-ribosyltransferase activities are intrinsic to the A1 peptide of choleragen. (1979) (47)
Effect of the A and B protomers of choleragen on release of trapped glucose from liposomes containing or lacking ganglioside GM1. (1977) (47)
ARD 1, a 64-kDa guanine nucleotide-binding protein with a carboxyl-terminal ADP-ribosylation factor domain. (1993) (47)
Effects of GTP on choleragen-catalyzed ADP ribosylation of membrane and soluble proteins. (1980) (47)
CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells (2018) (47)
Identification of a brefeldin A-insensitive guanine nucleotide-exchange protein for ADP-ribosylation factor in bovine brain. (1994) (47)
Cybr, a cytokine-inducible protein that binds cytohesin-1 and regulates its activity (2002) (47)
Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs (1994) (47)
Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis. (2007) (47)
Mono (ADP-ribosyl)transferases and their effects on cellular metabolism. (1981) (47)
ARD1, a 64-kDa bifunctional protein containing an 18-kDa GTP-binding ADP-ribosylation factor domain and a 46-kDa GTPase-activating domain. (1996) (47)
E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1). (2005) (46)
Pneumothorax after air travel in lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, and sarcoidosis. (2009) (46)
Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. (1997) (46)
Chemokine-Enhanced Chemotaxis of Lymphangioleiomyomatosis Cells with Mutations in the Tumor Suppressor TSC2 Gene1 (2009) (46)
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development (2005) (46)
Effect of ADP-ribosylation factor amino-terminal deletions on its GTP-dependent stimulation of cholera toxin activity. (1994) (46)
Fibrillar organization of fibronectin is expressed coordinately with cell surface gangliosides in a variant murine fibroblast (1986) (46)
Enzymatic and nonenzymatic ADP-ribosylation of cysteine (1994) (45)
Identification and characterization of receptors for vacuolating activity of subtilase cytotoxin (2006) (45)
Reversible airflow obstruction in lymphangioleiomyomatosis. (2009) (45)
Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation (2017) (45)
Choleragen activation of solubilized adenylate cyclase: requirement for GTP and protein activator for demonstration of enzymatic activity. (1977) (45)
Meningiomas in lymphangioleiomyomatosis. (2001) (44)
LY303511 (2-Piperazinyl-8-phenyl-4H-1-benzopyran-4-one) Acts via Phosphatidylinositol 3-Kinase-Independent Pathways to Inhibit Cell Proliferation via Mammalian Target of Rapamycin (mTOR)- and Non-mTOR-Dependent Mechanisms (2005) (44)
Natural history of pulmonary fibrosis in two subjects with the same telomerase mutation. (2011) (44)
Purification and characterization of ADP-ribosylarginine hydrolase from turkey erythrocytes. (1988) (44)
Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus. (2015) (44)
GTP but not GDP analogues promote association of ADP-ribosylation factors, 20-kDa protein activators of cholera toxin, with phospholipids and PC-12 cell membranes. (1992) (44)
ADP-ribosylation of human defensin HNP-1 results in the replacement of the modified arginine with the noncoded amino acid ornithine (2009) (43)
Molecular characterization of a glycosylphosphatidylinositol-linked ADP- ribosyltransferase from lymphocytes (1996) (43)
Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry. (2007) (43)
Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas. (2001) (43)
Choleragen-mediated release of trapped glucose from liposomes containing ganglioside GM1. (1976) (42)
BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin β1 (2007) (42)
Histone-dependent and histone-independent forms of an ADP-ribosyltransferase from human and turkey erythrocytes. (1981) (42)
Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1γ (2007) (42)
Rat RT6.2 and mouse Rt6 locus 1 are NAD+: arginine ADP ribosyltransferases with auto-ADP ribosylation activity. (1996) (42)
Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial (2017) (42)
Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis. (2011) (41)
Mechanism of activation of cholera toxin by ADP-ribosylation factor (ARF): both low- and high-affinity interactions of ARF with guanine nucleotides promote toxin activation. (1990) (41)
Gangliosides sensitize unresponsive fibroblasts to Escherichia coli heat-labile enterotoxin. (1979) (41)
Inhibition of bovine rod outer segment GTPase by Bordetella pertussis toxin. (1984) (41)
Hydrolysis of O-Acetyl-ADP-ribose Isomers by ADP-ribosylhydrolase 3* (2011) (41)
Substrate and effector specificity of a guanosine 3':5'-monophosphate phosphodiesterase from rat liver. (1977) (41)
Helicobacter pylori VacA induces apoptosis by accumulation of connexin 43 in autophagic vesicles via a Rac1/ERK-dependent pathway (2015) (40)
Activation of cholera toxin and Escherichia coli heat‐labile enterotoxins by ADP‐ribosylation factors, a family of 20 kDa guanine nucleotide‐binding proteins (1991) (40)
Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features (2018) (40)
Early Immune Response to the Components of the Type III System of Pseudomonas aeruginosa in Children with Cystic Fibrosis (2005) (40)
Inhibitory Effects of Polyphenols on Gastric Injury by Helicobacter pylori VacA Toxin (2005) (40)
Arthrosonography of the irritable hip in childhood: a review of 1 year's experience. (1986) (40)
Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution. (1993) (40)
Liposomes as model membranes for ligand-receptor interactions: studies with choleragen and glycolipids. (1979) (39)
Essential Domain of Receptor Tyrosine Phosphatase β (RPTPβ) for Interaction with Helicobacter pylori Vacuolating Cytotoxin* (2004) (39)
The changing face of a rare disease: lymphangioleiomyomatosis (2015) (39)
Selective amplification of an mRNA and related pseudogene for a human ADP-ribosylation factor, a guanine nucleotide-dependent protein activator of cholera toxin. (1990) (39)
Choleragen (cholera toxin): a bacterial lectin. (1979) (39)
Nitric oxide-independent, thiol-associated ADP-ribosylation inactivates aldehyde dehydrogenase. (1993) (38)
Activation of choleragen by thiol: protein disulfide oxidoreductase. (1980) (38)
Human and Giardia ADP-ribosylation factors (ARFs) complement ARF function in Saccharomyces cerevisiae. (1992) (38)
Enzymatic and chemical oxidation of gangliosides in cultured cells: effects of choleragen. (1977) (38)
Differential interaction of ADP-ribosylation factors 1, 3, and 5 with rat brain Golgi membranes. (1992) (38)
Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing (2011) (38)
Characterization of class II and class III ADP-ribosylation factor genes and proteins in Drosophila melanogaster. (1994) (38)
Cysteine-specific ADP-ribosylation of actin. (1994) (37)
Phospholipid- and GTP-dependent Activation of Cholera Toxin and Phospholipase D by Human ADP-ribosylation Factor-like Protein 1 (HARL1)* (1998) (37)
Amino acid-specific ADP-ribosylation: structural characterization and chemical differentiation of ADP-ribose-cysteine adducts formed nonenzymatically and in a pertussis toxin-catalyzed reaction. (1992) (37)
The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis (2020) (37)
Differential expression during development of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding protein activators of cholera toxin. (1991) (37)
Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosis. (2014) (36)
Modification of the ADP-ribosyltransferase and NAD Glycohydrolase Activities of a Mammalian Transferase (ADP-ribosyltransferase 5) by Auto-ADP-ribosylation* (1999) (35)
Type II heat-labile enterotoxin of Escherichia coli activates adenylate cyclase in human fibroblasts by ADP ribosylation (1987) (35)
Purification and characterization of a guanine nucleotide-exchange protein for ADP-ribosylation factor from spleen cytosol. (1996) (35)
Interaction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): Effects of FK506 (2003) (35)
Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis. (2000) (34)
Long‐Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis (2018) (34)
Effects of nucleoside triphosphates on choleragen-activated brain adenylate cyclase. (1980) (34)
Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis. (2014) (34)
Grape seed extract (2023) (34)
Resolution and activity of adenylate cyclase components in a zwitterionic cholate derivative [3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate]. (1982) (34)
Acetyl coenzyme A carboxylase. Purification and properties of the bovine adipose tissue enzyme. (1972) (33)
ADP-Ribosylarginine Hydrolases and ADP-Ribosyltransferases (1997) (33)
Binding of diphtheria toxin to phospholipids in liposomes. (1980) (33)
Molecular Characterization of the GTPase-activating Domain of ADP-ribosylation Factor Domain Protein 1 (ARD1)* (1998) (33)
Helicobacter pylori VacA Enhances Prostaglandin E2 Production through Induction of Cyclooxygenase 2 Expression via a p38 Mitogen-Activated Protein Kinase/Activating Transcription Factor 2 Cascade in AZ-521 Cells (2007) (33)
Selective regulation by pertussis toxin of insulin-induced activation of particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. (1983) (32)
Subtilase cytotoxin induces apoptosis in HeLa cells by mitochondrial permeabilization via activation of Bax/Bak, independent of C/EBF-homologue protein (CHOP), Ire1alpha or JNK signaling. (2010) (32)
Endogenous mono-ADP-ribosylation of the free Gbetagamma prevents stimulation of phosphoinositide 3-kinase-gamma and phospholipase C-beta2 and is activated by G-protein-coupled receptors. (2002) (32)
Salmonella enterotoxin (Stn) regulates membrane composition and integrity (2012) (32)
Characterization of a GTPase-activating Protein That Stimulates GTP Hydrolysis by Both ADP-ribosylation Factor (ARF) and ARF-like Proteins (1996) (32)
Poly ADP-ribosylation of protein. (1983) (32)
Identification of enzymatic activities which process protein bound mono(ADP-ribose). (1985) (32)
Nuclear localization and molecular partners of BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors. (2004) (31)
Expression in BALB/c and C57BL/6 mice of Rt6-1 and Rt6-2 ADP-ribosyltransferases that differ in enzymatic activity: C57BL/6 Rt6-1 is a natural transferase knockout. (1997) (31)
Choleragen-stimulated release of guanyl nucleotides from turkey erythrocyte membranes. (1982) (31)
Phosphatidylinositol 3-Kinase-dependent Suppression of the Human Inducible Nitric-oxide Synthase Promoter Is Mediated by FKHRL1* (2006) (31)
ADP ribosylation of membrane proteins from human fibroblasts. Effect of prior exposure of cells to choleragen. (1981) (31)
Identification of Subtilase Cytotoxin (SubAB) Receptors Whose Signaling, in Association with SubAB-Induced BiP Cleavage, Is Responsible for Apoptosis in HeLa Cells (2010) (30)
PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells. (2019) (30)
An RNA-binding protein gene (RBP1) of Saccharomyces cerevisiae encodes a putative glucose-repressible protein containing two RNA recognition motifs. (1993) (30)
Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex (2013) (30)
Amino acid specific ADP-ribosylation: specific NAD: arginine mono-ADP-ribosyltransferases associated with turkey erythrocyte nuclei and plasma membranes. (1986) (30)
Effects of Arfaptin 1 on Guanine Nucleotide-dependent Activation of Phospholipase D and Cholera Toxin by ADP-ribosylation Factor* (1998) (30)
Molecular characterization of a conserved, guanine nucleotide-dependent ADP-ribosylation factor in Drosophila melanogaster. (1993) (30)
Characterization of the human gene encoding ADP-ribosylation factor 1, a guanine nucleotide-binding activator of cholera toxin. (1992) (30)
Lymphangioleiomyomatosis and TSC2-/- cells. (2010) (29)
Pertussis toxin-catalyzed ADP-ribosylation: effects on the coupling of inhibitory receptors to the adenylate cyclase system. (1984) (29)
Effect of serum on ganglioside uptake and choleragen responsiveness of transformed mouse fibroblasts. (1978) (29)
Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing Pilot. (2018) (29)
LAM and other diseases characterized by smooth muscle proliferation (1999) (29)
ADP-ribosyltransferase activity of mono- and multi-(ADP-ribosylated) choleragen. (1980) (29)
Novel Subtilase Cytotoxin Produced by Shiga-Toxigenic Escherichia coli Induces Apoptosis in Vero Cells via Mitochondrial Membrane Damage (2009) (29)
Interaction of brefeldin A-inhibited guanine nucleotide-exchange protein (BIG) 1 and kinesin motor protein KIF21A (2008) (29)
PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4. (2012) (29)
Severity and outcome of cystic lung disease in women with tuberous sclerosis complex (2015) (29)
Distribution and mRNA Expression of Insulin-Like Growth Factor System in Pulmonary Lymphangioleiomyomatosis (2001) (28)
Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity. (1988) (28)
Association of Common Haplotypes of Surfactant Protein A1 and A2 (SFTPA1 and SFTPA2) Genes with Severity of Lung Disease in Cystic Fibrosis (2006) (28)
Self-learning to detect and segment cysts in lung CT images without manual annotation (2018) (28)
Pulmonary lymphangiomatosis. (2011) (28)
BIG1 and BIG2, brefeldin A-inhibited guanine nucleotide-exchange factors for ADP-ribosylation factors. (2005) (28)
Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity (2009) (28)
Lymphatic Involvement in Lymphangioleiomyomatosis (2008) (28)
DAP1, a Negative Regulator of Autophagy, Controls SubAB-Mediated Apoptosis and Autophagy (2014) (28)
Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis (2012) (28)
Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells (2006) (28)
CT grading of lung disease in lymphangioleiomyomatosis. (2012) (28)
Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease. (2009) (27)
Expression of gangliosides as receptors at the cell surface controls infection of NCTC 2071 cells by Sendai virus. (1986) (27)
Identification of Helicobacter pylori VacA in human lung and its effects on lung cells. (2015) (27)
ADP-ribosylation factors: a family of approximately 20-kDa guanine nucleotide-binding proteins that activate cholera toxin. (1994) (27)
Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis. (2006) (27)
Management of lymphangioleiomyomatosis (2014) (27)
Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis. (2015) (27)
Characterization of the human ADP-ribosylation factor 3 promoter. Transcriptional regulation of a TATA-less promoter. (1993) (27)
Inactivation of glutamine synthetases by an NAD:arginine ADP-ribosyltransferase. (1984) (27)
Giles F. Filley Lecture. Genetics and gene expression in lymphangioleiomyomatosis. (2002) (26)
Activation of phospholipase D by bradykinin and sphingosine 1-phosphate in A549 human lung adenocarcinoma cells via different GTP-binding proteins and protein kinase C delta signaling pathways. (2003) (26)
Enhanced expression of CCL20 in human Helicobacter pylori-associated gastritis. (2009) (26)
Involvement of ADP-ribosylation Factor 1 in Cholera Toxin-induced Morphological Changes of Chinese Hamster Ovary Cells* (2001) (26)
Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis. (2017) (26)
Paradoxical Effects of Rapamycin on Experimental House Dust Mite-Induced Asthma (2011) (26)
Requirement for both choleragen and pertussis toxin to obtain maximal activation of adenylate cyclase in cultured cells. (1984) (26)
Interaction of the GTP-binding and GTPase-activating Domains of ARD1 Involves the Effector Region of the ADP-ribosylation Factor Domain* (1997) (26)
The carboxyl transferase component of acetyl CoA carboxylase: structural evidence for intersubunit translocation of the biotin prosthetic group. (1971) (26)
Kinetic mechanisms of two NAD:arginine ADP-ribosyltransferases: the soluble, salt-stimulated transferase from turkey erythrocytes and choleragen, a toxin from Vibrio cholerae. (1985) (26)
Clinical and molecular insights into lymphangioleiomyomatosis. (2005) (26)
Effects of phospholipid and GTP on recombinant ADP-ribosylation factors (ARFs). Molecular basis for differences in requirements for activity of mammalian ARFs. (1992) (26)
Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis (2019) (26)
ART2, a T Cell Surface Mono-ADP-ribosyltransferase, Generates Extracellular Poly(ADP-ribose)* (2006) (25)
GTP-binding protein G alpha Z: its down-regulation by dexamethasone and its credentials as a mediator of antigen-induced responses in RBL-2H3 cells. (1991) (25)
Favorable Response to Antigonadal Therapy for a Benign Metastasizing Leiomyoma (2012) (25)
Report of workshop on lymphangioleiomyomatosis (1999) (25)
Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa. (2002) (25)
Mechanism of action of choleragen and the glycopeptide hormones: is the nicotinamide adenine dinucleotide glycohydrolase activity observed in purified hormone preparations intrinsic to the hormone? (1978) (25)
The Arf GTPase-activating Protein, ASAP1, Binds Nonmuscle Myosin 2A to Control Remodeling of the Actomyosin Network* (2016) (25)
Characterization of the gene for ADP-ribosylation factor (ARF) 2, a developmentally regulated, selectively expressed member of the ARF family of approximately 20-kDa guanine nucleotide-binding proteins. (1993) (24)
Selective expression of RT6 superfamily in human bronchial epithelial cells. (1999) (24)
CHAPTER 2 – Regulation of Fatty Acid Synthesis in Animal Tissues (1971) (24)
A mechanism for controlled access to GWAS data: experience of the GAIN Data Access Committee. (2013) (24)
Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status. (1998) (24)
Phenotypic distinctions between mosaic forms of tuberous sclerosis complex (2019) (24)
Benign Metastasizing Leiomyoma. (2016) (24)
ADP-ribosylation factors: a family of ∼20-kDa guanine nucleotide-binding proteins that activate cholera toxin (1994) (24)
Essential domain of receptor tyrosine phosphatase beta (RPTPbeta) for interaction with Helicobacter pylori vacuolating cytotoxin. (2004) (23)
Statins in lymphangioleiomyomatosis: a word of caution (2009) (23)
ADP-ribosylation factors, 20,000 M(r) guanine nucleotide-binding protein activators of cholera toxin and components of intracellular vesicular transport systems. (1993) (23)
Effect of protein kinase A on accumulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) in HepG2 cell nuclei. (2006) (23)
Isolation and characterization of the human gene for ADP-ribosylation factor 3, a 20-kDa guanine nucleotide-binding protein activator of cholera toxin. (1991) (23)
Identification of Critical, Conserved Vicinal Aspartate Residues in Mammalian and Bacterial ADP-ribosylarginine Hydrolases* (1999) (23)
A sensitive method for the detection of GM1-ganglioside in rat adipocyte preparations based on its interaction with choleragen. (1978) (22)
Bone mineral density in lymphangioleiomyomatosis. (2005) (22)
Structure and function of eukaryotic mono-ADP-ribosyltransferases. (1996) (22)
Structure of human ADP-ribosyl-acceptor hydrolase 3 bound to ADP-ribose reveals a conformational switch that enables specific substrate recognition (2018) (22)
Loss of choleragen receptors and ganglioside upon differentiation of 3T3-L1 preadipocytes. (1980) (22)
Toxin ADP-ribosyltransferases that act on adenylate cyclase systems. (1984) (22)
The RT6 (Art2) family of ADP-ribosyltransferases in rat and mouse (2004) (22)
CA‐125 in Disease Progression and Treatment of Lymphangioleiomyomatosis (2017) (22)
cAMP-dependent Protein Kinase A (PKA) Signaling Induces TNFR1 Exosome-like Vesicle Release via Anchoring of PKA Regulatory Subunit RIIβ to BIG2* (2008) (21)
cAMP-independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside GM1 in B cell activation. (1990) (21)
Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size. (2005) (21)
Association of Lymphangioleiomyomatosis (LAM) with Endosalpingiosis in the Retroperitoneal Lymph Nodes: Report of Two Cases (2001) (21)
Release of guanyl nucleotides from the regulatory subunit of adenylate cyclase. (1983) (21)
Fatal hemorrhage induced by subtilase cytotoxin from Shiga-toxigenic Escherichia coli. (2011) (21)
Localization of ADP-ribosylation factor domain protein 1 (ARD1) in lysosomes and Golgi apparatus. (1998) (21)
Uptake of Shiga‐toxigenic Escherichia coli SubAB by HeLa cells requires an actin‐ and lipid raft‐dependent pathway (2014) (21)
Cytohesin-1 in 2001. (2002) (20)
Pertussis toxin-catalyzed ADP-ribosylation of G(o) alpha with mutations at the carboxyl terminus. (1992) (20)
Effect of differentiation on the adenylate cyclase system of 3T3-C2 and 3T3-L1 cells. Determination of choleragen substrates in differentiating 3T3-L1 and nondifferentiating 3T3-C2 cells. (1982) (20)
Effects of Site-Directed Mutagenesis ofEscherichia coli Heat-Labile Enterotoxin on ADP-Ribosyltransferase Activity and Interaction with ADP-Ribosylation Factors (1999) (20)
Different forms of Go alpha mRNA arise by alternative splicing of transcripts from a single gene on human chromosome 16 (1991) (20)
Pertussis toxin: lessons from biological and biochemical effects in different cells. (1984) (20)
Functional Role of ADP-Ribosyl-Acceptor Hydrolase 3 in poly(ADP-Ribose) Polymerase-1 Response to Oxidative Stress. (2016) (20)
Effect of self-association on activity of an ADP-ribosyltransferase from turkey erythrocytes. Conversion of inactive oligomers to active protomers by chaotropic salts. (1981) (20)
Multiple cytosolic forms of hepatic β-hydroxy-β-methyglutaryl coA synthase: Possible regulatory role in cholesterol synthesis (1972) (20)
Effects of chymotrypsin and a calcium-dependent protein activator on guanosine 3',5'-monophosphate phosphodiesterase from rat liver. (1978) (19)
The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform. (2010) (19)
Molecular characterization of a glycosylphosphatidylinositol-linked ADP-ribosyltransferase from lymphocytes. (1996) (19)
Characterization of Cholix Toxin-induced Apoptosis in HeLa Cells* (2011) (19)
Association of guanine nucleotide-exchange protein BIG1 in HepG2 cell nuclei with nucleolin, U3 snoRNA, and fibrillarin (2008) (19)
Epidemiology, pathogenesis and diagnosis of lymphangioleiomyomatosis (2016) (19)
Regulation of ADP-ribosylation factor (ARF) expression. Cross-species conservation of the developmental and tissue-specific alternative polyadenylation of ARF 4 mRNA. (1992) (19)
Cytotoxicity and recognition of receptor‐like protein tyrosine phosphatases, RPTPα and RPTPβ, by Helicobacter pylori m2VacA (2005) (19)
Enhancement of cholera toxin-catalyzed ADP-ribosylation by guanine nucleotide-binding proteins. (1992) (19)
Beta-2-adrenergic receptor polymorphisms in cystic fibrosis (2007) (19)
NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline. (2016) (19)
Thiols Mediate Superoxide-dependent NADH Modification of Glyceraldehyde-3-phosphate Dehydrogenase* (1999) (18)
Low-density Lipoprotein Receptor-related Protein-1 ( LRP 1 ) Mediates Autophagy and Apoptosis Caused by Helicobacter pylori (2012) (18)
Mechanism of inhibition of transducin guanosine triphosphatase activity by vanadate. (1988) (18)
The T cell marker RT6 in a rat model of autoimmune diabetes. (1997) (18)
Fibrous cephalic plaques in tuberous sclerosis complex (2017) (18)
Participation of a guanine nucleotide-binding protein cascade in cholera toxin activation of adenylate cyclase. (1989) (18)
cAMP-independent effects of cholera toxin on B cell activation. III. Cholera toxin A subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation. (1995) (18)
Identification of residues critical for enzymatic activity in the domain encoded by exons 8 and 9 of the human inducible nitric oxide synthase. (2001) (18)
Heterologous desensitization of adenylate cyclase with prostaglandin E1 alters sensitivity to inhibitory as well as stimulatory agonists. (1985) (18)
Optimizing treatments for lymphangioleiomyomatosis (2012) (18)
Specific Functional Interaction of Human Cytohesin-1 and ADP-ribosylation Factor Domain Protein (ARD1)* (2000) (18)
Regulation of Subtilase Cytotoxin-Induced Cell Death by an RNA-Dependent Protein Kinase-Like Endoplasmic Reticulum Kinase-Dependent Proteasome Pathway in HeLa Cells (2012) (18)
Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling (2012) (18)
Activation of an NAD:arginine ADP-ribosyltransferase by histone. (1982) (18)
ADP-ribosylarginine hydrolases and ADP-ribosyltransferases. Partners in ADP-ribosylation cycles. (1997) (17)
St. George's Respiratory Questionnaire has longitudinal construct validity in lymphangioleiomyomatosis. (2013) (17)
BIG1, a Brefeldin A–Inhibited Guanine Nucleotide-Exchange Protein Modulates ATP-Binding Cassette Transporter A-1 Trafficking and Function (2013) (17)
Tissue and species distribution of mRNA encoding two ADP-ribosylation factors, 20-kDa guanine nucleotide binding proteins. (1989) (17)
ADP-ribosyltransferase type A from turkey erythrocytes modifies actin at Arg-95 and Arg-372. (1995) (17)
Mechanism of action of choleragen andE. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation (1981) (17)
Identification of the probable site of choleragen-catalyzed ADP-ribosylation in a Go alpha-like protein based on cDNA sequence. (1986) (17)
Inactivation of bacterial glutamine synthetase by ADP-ribosylation. (1990) (17)
Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches (2017) (17)
Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals (2016) (17)
Chest CT Scan at Radiation Dose of a Posteroanterior and Lateral Chest Radiograph Series: A Proof of Principle in Lymphangioleiomyomatosis (2019) (17)
Involvement of lymphatics in lymphangioleiomyomatosis. (2009) (17)
Tricarboxylic acid activator-induced changes at the active site of acetyl-CoA carboxylase. (1970) (17)
BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors. (2002) (17)
Guanine nucleotide-dependent ADP-ribosylation of soluble rho catalyzed by Clostridium botulinum C3 ADP-ribosyltransferase. Isolation and characterization of a newly recognized form of rhoA. (1990) (17)
Immunological and biochemical differentiation of guanyl nucleotide binding proteins: interaction of Go alpha with rhodopsin, anti-Go alpha polyclonal antibodies, and a monoclonal antibody against transducin alpha subunit and Gi alpha. (1987) (17)
Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein. (1989) (17)
Mutations of the functional ARH1 allele in tumors from ARH1 heterozygous mice and cells affect ARH1 catalytic activity, cell proliferation and tumorigenesis (2015) (16)
Activation of an erythrocyte NAD:arginine ADP-ribosyltransferase by lysolecithin and nonionic and zwitterionic detergents. (1984) (16)
Guanine nucleotide dependent formation of a complex between choleragen (cholera toxin) a subunit and bovine brain ADP-ribosylation factor. (1991) (16)
The Guanine Nucleotide Exchange Protein for ADP-ribosylation Factor 6, ARF-GEP100/BRAG2, Regulates Phagocytosis of Monocytic Phagocytes in an ARF6-dependent Process* (2010) (16)
Imaging features of lymphangioleiomyomatosis: diagnostic pitfalls. (2011) (16)
Subtilase cytotoxin produced by locus of enterocyte effacement‐negative Shiga‐toxigenic Escherichia coli induces stress granule formation (2016) (16)
Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair. (2018) (16)
Levels of Art2+ Cells but not Soluble Art2 Protein Correlate with Expression of Autoimmune Diabetes in the BB Rat (2001) (16)
Prostaglandins increase GTP hydrolysis by membranes from human mononuclear cells. (1980) (16)
Molecular cloning and DNA sequence analysis of the human guanine nucleotide-binding protein Goα (1988) (15)
Histologic variants of periungual fibromas in tuberous sclerosis complex. (2011) (15)
Of fi cial American Thoracic Society / Japanese Respiratory Society Clinical Practice Guidelines : Lymphangioleiomyomatosis Diagnosis and Management (2016) (15)
Signal transduction by receptor-responsive guanyl nucleotide-binding proteins: modulation by bacterial toxin-catalyzed ADP-ribosylation. (1987) (15)
Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis. (2010) (15)
CT of pleural abnormalities in lymphangioleiomyomatosis and comparison of pleural findings after different types of pleurodesis. (2006) (15)
Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Ha-ras-encoded p21. (1985) (15)
Characterization of NAD:arginine ADP-ribosyltransferases (2004) (15)
Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation. (2017) (15)
Alternative splicing of the guanine nucleotide-binding regulatory protein Go alpha generates four distinct mRNAs. (1994) (15)
Functional Genomics of Lung Disease (2004) (15)
Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models (2013) (15)
ADP-ribosylarginine hydrolases (1994) (15)
Acidic Conditions Enhance Bactericidal Effects of Sodium Bisulfite on Helicobacter pylori (2005) (14)
Activation of toxin ADP-ribosyltransferases by the family of ADP-ribosylation factors. (1997) (14)
The activation of acetyl CoA carboxylase by tricarboxylic acids. (1970) (14)
Isolation of an amino-terminal deleted recombinant ADP-ribosylation factor 1 in an activated nucleotide-free state. (1995) (14)
Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis (2019) (14)
An enzyme-linked immunosorbent assay-based system for determining the physiological level of poly(ADP-ribose) in cultured cells. (2016) (14)
Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis (2018) (14)
Degradation of choleragen bound to cultured human fibroblasts and mouse neuroblastoma cells. (1983) (14)
A simplified procedure for hybridization of RNA blots. (1992) (14)
Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways. (2019) (14)
The C/A(-18) polymorphism in the surfactant protein B gene influences transcription and protein levels of surfactant protein B. (2007) (14)
Genetic heterogeneity of circulating cells from patients with lymphangioleiomyomatosis with and without lung transplantation. (2015) (14)
Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells. (2016) (14)
Identification and characterization of the Aeromonas sobria hemolysin glycoprotein receptor on intestine 407 cells. (1999) (13)
Expression of human telomerase reverse transcriptase in lymphangioleiomyomatosis. (2002) (13)
Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2. (2011) (13)
Nuclear localization of vascular endothelial growth factor-D and regulation of c-Myc-dependent transcripts in human lung fibroblasts. (2014) (13)
Effects of nitroprusside and nitroglycerin on cGMP content and PGI2 formation in aorta and vena cava. (1989) (13)
Helicobacter pylori VacA, acting through receptor protein tyrosine phosphatase α, is crucial for CagA phosphorylation in human duodenum carcinoma cell line AZ-521 (2016) (13)
Effect of beta-agonists on LAM progression and treatment (2018) (13)
Soluble guanine nucleotide-dependent ADP-ribosylation factors in activation of adenylyl cyclase by cholera toxin. (1991) (13)
Hydrophobicity and Subunit Interactions of Rod Outer Segment Proteins Investigated Using Triton X-114 Phase Partitioning (*) (1995) (13)
Activation of toxin ADP-ribosyltransferases by eukaryotic ADP-ribosylation factors (1999) (13)
The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models (2018) (13)
New Insights into VacA Intoxication Mediated through Its Cell Surface Receptors (2016) (13)
Isolation of recombinant ADP-ribosylation factor 6, an approximately 20-kDa guanine nucleotide-binding protein, in an activated GTP-bound state. (1994) (13)
Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation. (1988) (13)
Effects of pertussis toxin on cAMP and cGMP responses to carbamylcholine in N1E-115 neuroblastoma cells. (1985) (13)
Regulation of collagen production by the beta-adrenergic system. (1981) (13)
Selective probing of ADP-ribosylation reactions with oxidized 2'-deoxy-nicotinamide adenine dinucleotide. (1988) (12)
Dermatologic Manifestations of Tuberous Sclerosis Complex (TSC) (2010) (12)
Inhibition of the GTPase activity of transducin by an NAD+:arginine ADP-ribosyltransferase from turkey erythrocytes. (1987) (12)
Cytotoxicity and recognition of receptor-like protein tyrosine phosphatases, RPTPalpha and RPTPbeta, by Helicobacter pylori m2VacA. (2005) (12)
Interaction of choleragen and thyrotropin with bovine thyroid adenylate cyclase. (1979) (12)
Computer-aided grading of lymphangioleiomyomatosis (LAM) using HRCT (2008) (12)
Involvement of N-Myristoylation in Monoclonal Antibody Recognition Sites on Chimeric G Protein α Subunits (*) (1995) (12)
A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis (2019) (12)
Regulatory Role of Arginine 204 in the Catalytic Activity of Rat Alloantigens ART2a and ART2b* (2003) (12)
A diagnostic and management algorithm for individuals with an isolated skin finding suggestive of tuberous sclerosis complex (2017) (12)
Identification of Regulatory Domains in ADP-ribosyltransferase-1 That Determine Transferase and NAD Glycohydrolase Activities* (2003) (12)
Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3 (2017) (12)
Characterization of a GDP Dissociation Inhibitory Region of ADP-ribosylation Factor Domain Protein ARD1* (1997) (12)
Multiple forms of Go alpha mRNA: analysis of the 3'-untranslated regions. (1990) (12)
ADP-ribosylation factor domain protein 1 (ARD1), a multifunctional protein with ubiquitin E3 ligase, GAP, and ARF domains. (2005) (11)
Helicobacter pylori VacA toxin causes cell death by inducing accumulation of cytoplasmic connexin 43 (2015) (11)
Production of antibodies against rhodopsin after immunization with beta gamma-subunits of transducin: evidence for interaction of beta gamma-subunits of guanosine 5'-triphosphate binding proteins with receptor. (1987) (11)
Binding of choleragen and anti-ganglioside antibodies to gangliosides incorporated into preformed liposomes. (1983) (11)
Activation of cholera toxin by ADP-ribosylation factors. (1994) (11)
Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. (2013) (11)
Cloning of a Saccharomyces cerevisiae gene encoding a protein homologous to allantoicase of Neurospora crassa (1991) (11)
Expression of Go alpha mRNA and protein in bovine tissues. (1989) (11)
Effect of bradykinin on prostaglandin production by human skin fibroblasts in culture. (1985) (11)
Characterization of mammalian ADP-ribosylation cycles. (1995) (11)
The ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD+ Hydrolysis. (2019) (11)
Identification and characterization of an ADP-ribosylation factor in Plasmodium falciparum. (1997) (11)
Effects of nucleotides on activity of a purified ADP-ribosyltransferase from turkey erythrocytes. (1982) (11)
Acetyl coenzyme A carboxylase. IV. Biotinyl prosthetic group-independent malonyl coenzyme A decarboxylation and carbosyl transfer: generalization to other biotin enzymes. (1972) (11)
Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice (2018) (11)
Microinjection of a 19-kDa guanine nucleotide-binding protein inhibits maturation of Xenopus oocytes. (1989) (11)
ADP-Ribosylation: Metabolic Effects and Regulatory Functions (1994) (11)
Characterization of recombinant and endogenous ADP-ribosylation factors synthesized in Sf9 insect cells. (1993) (10)
Encyclopedia of Dietary Supplements (Online) (2004) (10)
Apparent Sporadic Lymphangioleiomyomatosis in a Man as a Result of Extreme Mosaicism for a TSC2 Mutation. (2017) (10)
The RT6 (Art2) family of ADP-ribosyltransferases in rat and mouse. (1999) (10)
Guanine nucleotide-binding proteins (G proteins) in activation of adenylyl cyclase: lessons learned from cholera and "travelers' diarrhea". (1989) (10)
Differential binding of IL-3 and GM-CSF to human monocytes. (1992) (10)
Structural Elements of ADP-ribosylation Factor 1 Required for Functional Interaction with Cytohesin-1* (1999) (10)
Genetics and Gene Expression in Lymphangioleiomyomatosis: Giles F. Filley Lecture (2002) (10)
Prevalence of uterine leiomyomas in lymphangioleiomyomatosis. (2011) (10)
Effect of temperature and host factors on the activities of pertussis toxin and Bordetella adenylate cyclase. (1994) (10)
The α7 Integrin as a Target Protein for Cell Surface Mono-ADP-Ribosylation in Muscle Cells (1997) (10)
Activation of cholera toxin by ADP-ribosylation factors: 20-kDa guanine nucleotide-binding proteins. (1994) (9)
Vibrio cholerae Cholix Toxin-Induced HepG2 Cell Death is Enhanced by Tumor Necrosis Factor-Alpha Through ROS and Intracellular Signal-Regulated Kinases (2017) (9)
Common structure of the catalytic sites of mammalian and bacterial toxin ADP-ribosyltransferases (1994) (9)
Effect of salicylates on histamine and L-histidine metabolism. Inhibition of imidazoleacetate phosphoribosyl transferase. (1976) (9)
Lung transplantation for rare pulmonary diseases. (2005) (9)
The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells. (2010) (9)
Cholix toxin, an eukaryotic elongation factor 2 ADP‐ribosyltransferase, interacts with Prohibitins and induces apoptosis with mitochondrial dysfunction in human hepatocytes (2019) (9)
The natural history of renal cysts in an infant with tuberous sclerosis: evaluation with ultrasound. (1988) (9)
Nitric oxide and NAD-dependent protein modification (1994) (9)
Nipple angiofibromas with loss of TSC2 are associated with tuberous sclerosis complex (2015) (9)
Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin. (1986) (9)
Interaction of BIG 2 , a brefeldin A-inhibited guanine nucleotide-exchange protein , with exocyst protein Exo 70 (2005) (9)
The alpha 7 integrin as a target protein for cell surface mono-ADP-ribosylation in muscle cells. (1997) (9)
Summary for Clinicians: Lymphangioleiomyomatosis Diagnosis and Management Clinical Practice Guideline (2017) (9)
S-LAM in a man? (2007) (8)
Effects of pertussis toxin-catalyzed ADP-ribosylation on interactions of transducin and the inhibitory GTP-binding protein of adenylate cyclase with guanyl nucleotides. (1985) (8)
Bone Marrow-Derived Mesenchymal Stromal Cells (MSCs) Modulate the Inflammatory Character of Alveolar Macrophages from Sarcoidosis Patients (2020) (8)
Conservation of a 23-kDa human transplantation antigen in mammalian species. (1992) (8)
Cell Death Signaling Pathway Induced by Cholix Toxin, a Cytotoxin and eEF2 ADP-Ribosyltransferase Produced by Vibrio cholerae (2020) (8)
T2-weighted Lung Imaging Using a 0.55-T MRI System. (2021) (8)
Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells (2019) (8)
Oxygen‐enhanced functional lung imaging using a contemporary 0.55 T MRI system (2021) (8)
Rates of change in FEV1 and DLCO as potential indicators for mTOR inhibitor therapy in premenopausal lymphangioleiomyomatosis patients (2018) (8)
Specificity in protein-membrane associations: the interaction of gangliosides with Escherichia coli heat-labile enterotoxin and choleragen. (1982) (8)
Active Surveillance of Nonfatty Renal Masses in Patients With Lymphangioleiomyomatosis: Use of CT Features and Patterns of Growth to Differentiate Angiomyolipoma From Renal Cancer. (2017) (8)
Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts (2020) (7)
Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules. (2015) (7)
Activation of cholera toxin by ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins. (1992) (7)
Endogenous mono-ADP-ribosylation of the free G bc prevents stimulation of phosphoinositide 3-kinase- c and phospholipase C- b 2 and is activated by G-protein-coupled receptors (7)
Integrin a7 as Substrate for a Glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the Surface of Skeletal Muscle Cells* (2001) (7)
An 18-kDa Domain of a Glycosylphosphatidylinositol-linked NAD:Arginine ADP-Ribosyltransferase Possesses NAD Glycohydrolase Activity* (1997) (7)
Separation of the 24 kDa substrate for botulinum C3 ADP-ribosyltransferase and the cholera toxin ADP-ribosylation factor. (1988) (7)
Effects of d- and l-propranolol on the responsiveness of human fibroblasts to choleragen and prostaglandin E1. (1981) (7)
ARH1 in Health and Disease (2020) (7)
A diagnostic algorithm for enhanced detection of mosaic tuberous sclerosis complex in adults (2019) (7)
Nonenzymatic Conversion of ADP-Ribosylated Arginines to Ornithine Alters the Biological Activities of Human Neutrophil Peptide-1 (2014) (7)
Interaction of Integrin α7β1 in C2C12 Myotubes and in Solution with Laminin (1998) (7)
Chapter 36 – Mechanism of Action of Escherichia coli Heat-Labile Enterotoxin: Activation of Adenylate Cyclase by ADP-Ribosylation (1982) (7)
Birt-Hogg-Dubé syndrome initially diagnosed as tuberous sclerosis complex (2019) (7)
Detection of NAD:arginine ADPribosyltransferases in animal tissues using 125I-labeled 1-(p-hydroxyphenyl) 2-guanidinoethane as ADPribose acceptor. (1985) (6)
Characterization of NAD:arginine ADP-ribosyltransferases. (1999) (6)
Progress in the treatment of lymphangioleiomyomatosis: from bench to bedside. (2012) (6)
ADP-Ribosyl-Acceptor Hydrolase Activities Catalyzed by the ARH Family of Proteins. (2018) (6)
BRAF and NRAS mutations in circulating Langerhans-like CD1a+ cells in a patient with pulmonary Langerhans’ cell histiocytosis (2017) (6)
Effect of mild temperature shift on poly(ADP-ribose) and γH2AX levels in cultured cells. (2016) (6)
Alternative polyadenylation sites of human endothelial nitric oxide synthase mRNA. (2007) (6)
CHAPTER 8 – Participation of Guanine Nucleotide-Binding Protein Cascade in Activation of Adenylyl Cyclase by Cholera Toxin (Choleragen) (1990) (6)
Characterization of high density lipoprotein-bound and soluble RT6 released following administration of anti-RT6.1 monoclonal antibody. (1998) (6)
Pau d’Arco or Lapacho (Tabebuia) = Walter H. Lewis, Adewole L. Okunade, and Memory P.F. Elvin-Lewis (2004) (6)
Activation and stabilization of the catalytic unit of adenylate cyclase. (1985) (6)
The Adult Phenotype of Tuberous Sclerosis Complex. (2016) (6)
Vertebrate mono-ADP-ribosyltransferases (1994) (5)
Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1 (2011) (5)
Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going (2009) (5)
Familial Pulmonary Fibrosis: Natural History Of Preclinical Disease (2010) (5)
Effect of fasting on the size of lymphangioleiomyomas in patients with lymphangioleiomyomatosis. (2015) (5)
GTP stabilization of adenylate cyclase activated and ADP-ribosylated by choleragen. (1981) (5)
Circulating Lymphangioleiomyomatosis Tumor Cells With Loss of Heterozygosity in the TSC2 Gene Show Increased Aldehyde Dehydrogenase Activity. (2019) (5)
[44] NAD: Arginine mono-ADP-ribosyltransferases from animals cells (1984) (5)
Metabolic Changes in Lymphangioleiomyomatosis Patients Treated with Sirolimus and Hydroxychloroquine. (2019) (5)
ARF-directed guanine-nucleotide-exchange (GEP) proteins. (2002) (5)
Clinical CT underestimation of the percentage volume occupied by cysts in patients with lymphangioleiomyomatosis. (2019) (5)
Alterations of adenylyl cyclase-linked G proteins in rat liver during aging. (1996) (5)
Use of whole-exome sequencing for the diagnosis of atypical Birt-Hogg-Dubé syndrome. (2014) (5)
Cytohesin-1: structure, function, and ARF activation. (2005) (5)
3T3-L1 preadipocyte differentiation and poly(ADP-ribose) synthetase (2004) (5)
Kinetic analysis of agonist-receptor interactions. Model for the "irreversible" binding of choleragen to human fibroblasts. (1982) (5)
Affinity chromatographic procedure for the quantitative recovery of DNA fragments from agarose gels. (1986) (5)
The Function of GPI-Anchored Proteins (2000) (5)
Placental and intestinal alkaline phosphatases are receptors for Aeromonas sobria hemolysin. (2005) (5)
Involvement of a guanine nucleotide‐exchange protein, ARF‐GEP100/BRAG2a, in the apoptotic cell death of monocytic phagocytes (2006) (5)
Purification and properties of ARD1, an ADP-ribosylation factor (ARF)-related protein with GTPase-activating domain. (2001) (5)
Role of guanine nucleotide-binding proteins in Clostridium botulinum pathology: purification of substrates for Clostridium botulinum C3 ADP-ribosyltransferase with different requirements for GTP and phospholipids. (1990) (5)
Generalised mosaicism for TSC2 mutation in isolated lymphangioleiomyomatosis (2019) (4)
Identification of thiol:protein disulfide oxidoreductase activity in cultured human fibroblasts: dependence of enzyme activity on growth conditions. (1983) (4)
ADP-RIBOSYLATION OF PROTEINS: AN OVERVIEW (1983) (4)
Mouse RT6 locus 1 and rat RT6.2 are NAD+. Arginine ADP-ribosyltransferases with auto-ADP-ribosylation activity. (1997) (4)
Characterization of NAD: Arginine Mono(ADP-Ribosyl)-Transferases in Turkey Erythrocytes: Determinants of Substrate Specificity (1985) (4)
Immunological characterization of guanine nucleotide-binding proteins: effects of a monoclonal antibody against the gamma subunit of transducin on guanine nucleotide-binding protein-receptor interactions. (1990) (4)
Mono(ADP-ribosyl)ation of poly(ADP-ribose)polymerase by cholera toxin. (1991) (4)
Eruptive linear papules on the abdomen of a woman with ascites. (2004) (4)
Human alcohol dehydrogenase 1 is an acceptor protein for polyADP-ribosylation. (2019) (4)
Bacterial Cyclodipeptides Target Signal Pathways Involved in Malignant Melanoma (2020) (4)
Incidence of Pneumothorax in Patients With Lymphangioleiomyomatosis Undergoing Pulmonary Function and Exercise Testing. (2016) (4)
Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis. (2019) (4)
Regulation by bradykinin of its receptor and of receptor-mediated prostacyclin formation in cultured human fibroblasts. (1983) (4)
Interaction of integrin alpha 7 beta 1 in C2C12 myotubes and in solution with laminin. (1998) (4)
Pertussis toxin-catalyzed ADP-ribosylation of adenylate cyclase. Effects of guanyl nucleotides and rhodopsin. (1985) (4)
ADP-ribosylation factors: protein activators of cholera toxin. (1993) (4)
Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC 1 activation (2019) (4)
Response Element Binding Protein , and NF-Activating Transcription Factor-2 , cAMP Reveals a Prominent Role for p 38 MAPK in VacA Induction of IL-8 in U 937 Cells pylori Helicobacter (2008) (4)
Mechanism of inhibition of Shiga-toxigenic Escherichia coli SubAB cytotoxicity by steroids and diacylglycerol analogues (2018) (4)
Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial (2020) (4)
The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis. (2020) (4)
X‐ray microtomosynthesis of unstained pathology tissue samples (2021) (4)
BH3-only protein Bim is associated with the degree of Helicobacter pylori-induced gastritis and is localized to the mitochondria of inflammatory cells in the gastric mucosa. (2015) (4)
Serum VEGF-D Levels in Patients with Lymphangioleiomyomatosis (LAM) Reflect Lymphatic Involvement. (2009) (4)
Lymphangioleiomyomatosis: Abdominopelvic CT and US (2000) (4)
Structural and functional characterization of ADP-ribosylation factors, 20 kDa guanine nucleotide-binding proteins that activate cholera toxin. (1990) (3)
Expression in human endothelial cells of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins involved in the initiation of vesicular transport. (1996) (3)
Histopathological features of fibrous cephalic plaques in tuberous sclerosis complex (2021) (3)
Molecular cloning and characterization of lymphocyte and muscle ADP-ribosyltransferases. (1997) (3)
Characterization of the GTP-binding component of the adenylate cyclase system in isolated myocardial muscle cells. (1982) (3)
Optimization of a secondary VOI protocol for lung imaging in a clinical CT scanner (2018) (3)
Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancer. (2015) (3)
Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort (2018) (3)
Mechanism of Cholera Toxin Action: ADP-Ribosylation Factors as Stimulators of Cholera Toxin-Catalyzed ADP-Ribosylation and Effectors in Intracellular Vesicular Trafficking Events (2000) (3)
High Molecular Weight Factor in FCS Inhibits Helicobacter pylori VacA‐Binding to Its Receptor, RPTPβ, on AZ‐521 (2003) (3)
Reply to Yanagisawa: Treatment of Pulmonary Lymphangioleiomyomatosis during Pregnancy. (2018) (3)
An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases. (2017) (3)
Effects of nitroprusside on the bradykinin responsiveness of human fibroblasts. (1986) (3)
Chapter 37 – Purification and Properties of NAD:Arginine ADP-Ribosyltransferases from Animal Cells (1982) (3)
NAD:ARGININE ADP-RIBOSYLTRANSFERASES: ENZYMATIC ACTIVITIES IN ANIMAL CELLS AND BACTERIAL TOXINS (1983) (3)
Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis (2021) (3)
PERTUSSIS TOXIN-CATALYZED ADP-RIBOSYLATION: EFFECTS ON COUPLING OF INHIBITORY RECEPTORS TO ADENYLATE CYCLASE (1985) (3)
Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells. (1983) (3)
Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene. (2005) (3)
Mycobacterial infection masquerading as cutaneous sarcoidosis (2009) (3)
Interspecies relationships among ADP-ribosylation factors (ARFs): Evidence of evolutionary pressure to maintain individual identities (1996) (3)
Isolation and immunological properties of adenosine kinase. (1989) (2)
Deduced amino acid sequence of bovine retinal G . , , , : Similarities to other guanine nucleotide-binding proteins ( adenylate cyclase / cholera toxin / peftussis toxin / transducin ) (2)
Characterization of the Family of Mammalian Genes Encoding ADP- ribosylation Factors (1992) (2)
Reishi or Ling Zhi (Ganoderma lucidum) = Solomon P. Wasser (2004) (2)
Focus on Lymphangioleiomyomatosis. Introduction. (2010) (2)
Study of the Stn protein in Salmonella; a regulator of membrane composition and integrity. (2015) (2)
Effect of protein kinase A on accumulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 ( BIG 1 ) in HepG 2 cell nuclei (2006) (2)
Assessment of Lung Structure and Regional Function Using 0.55 T MRI in Patients With Lymphangioleiomyomatosis. (2021) (2)
Mono-ADP-Ribosylation Catalyzed by Arginine-Specific ADP-Ribosyltransferases. (2018) (2)
Cholera Toxin and Escherichia coli Heat‐Labile Enterotoxin: Biochemical Methods for Assessing Enzymatic Activities (2008) (2)
NAD: arginine mono-ADP-ribosyltransferases from animal cells. (1984) (2)
DAP 1 , a Negative Regulator of Autophagy , Controls SubAB-Mediated Apoptosis and Autophagy (2014) (2)
Helicobacter pylori VacA Exhibits Pleiotropic Actions in Host Cells (2016) (2)
Ginseng, Asian (Panax ginseng) = Fabio Soldati (2004) (2)
Subtilase cytotoxin induces a novel form of Lipocalin 2, which promotes Shiga-toxigenic Escherichia coli survival (2020) (2)
Molecular cloning and DNA sequence analysis of the human guanine nucleotide-binding protein Go alpha. (1988) (2)
Miliary fibromas in tuberous sclerosis complex (2021) (2)
ARH Family of ADP-Ribose-Acceptor Hydrolases (2022) (2)
Host response to the subtilase cytotoxin produced by locus of enterocyte effacement‐negative Shiga‐toxigenic Escherichia coli (2020) (2)
Genetic studies yield clues to the pathogenesis of Langerhans cell histiocytosis (2016) (2)
Altered regulation of adenylate cyclase after toxin-catalyzed ADP-ribosylation. (1985) (2)
Ahead of the curve. (2011) (2)
ETV2 regulates PARP-1 binding protein to induce ER stress–mediated death in tuberin-deficient cells (2022) (2)
Fibroblasts: important producers and targets of inflammatory prostaglandins in the lungs. (1983) (2)
Comparison of the intracellular pathways of immunoglobulin-G and low density lipoprotein in cultured human term trophoblast cells (1993) (2)
Activation of a rat liver NAD glycohydrolase by histone. (1982) (2)
A Review of Clinical and Morphological Features (2000) (2)
Cranberry (Vaccinium macrocarpon) Aiton = Marguerite A. Klein (2004) (2)
Benign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice (2021) (2)
Pleiotropic effects of nitric oxide on ADP-ribosylation, covalent binding of NAD, and catalytic activity of glyceraldehyde-3-phosphate and aldehyde dehydrogenases. (1993) (2)
Molecular engineering of cholera toxin. (1995) (1)
A PARP inhibitor, rucaparib, improves cardiac dysfunction in ADP-ribose-acceptor hydrolase 3 (Arh3) deficiency (2023) (1)
a-Lipoic Acid/Thioctic Acid = Donald B. McCormick (2004) (1)
Introduction to symposium: clinical and molecular insights from uncommon lung diseases. (2001) (1)
Lymphangioleiomyomatosis (LAM): Molecular Insights into mTOR Regulation Lead to Targeted Therapies (2016) (1)
Salmonella enterotoxin (Stn) regulates membrane composition and integrity (2012) (1)
Cholera Toxin: Mechanism of Action and Potential Use in Vaccine Development (2008) (1)
Nonenzymatic ADP-ribosylation of Cysteine (1992) (1)
Mechanism of Action of Choleragen: Effect of Toxin on Binding of Guanyl Nucleotides (1985) (1)
ADP-Ribosylation Factor-Like 8B (2012) (1)
Needle in the Haystack: Finding the Elusive Lymphangioleiomyomatosis Cell (2020) (1)
Abstract 2445: Estrogen promotes tumorigenesis by ADP-ribosyl-acceptor hydrolase 1 (ARH1)-deficient cells and mice (2014) (1)
Poly(ADP-ribose) Polymerase 1 Mediates Rab5 Inactivation after DNA Damage (2022) (1)
Model for delayed wound healing in scorbutic animals suppression of collagen production by prostaglandin in ascorbate deficient human fibroblasts (1981) (1)
Long-term effects of sirolimus on human skin TSC2-null fibroblast-like cells. (2021) (1)
CELLULAR HETEROGENEITY IN LYMPHANGIOLEIOMYOMATOSIS (1999) (1)
Identification of Disseminated CD44v6+/CD9+Cells withTSC2Loss of Heterozygosity in Patients with Lymphangioleiomyomatosis. (2009) (1)
Characterization of the Gene for ADP-ribosylation Factor ( ARF ) 2 , a Developmentally Regulated , Selectively Expressed Member of the ARF Family of-20-kDa Guanine Nucleotide-binding Proteins * (2001) (1)
A novel endoplasmic stress mediator, Kelch domain containing 7B (KLHDC7B), increased Harakiri (HRK) in the SubAB-induced apoptosis signaling pathway (2021) (1)
Author response: Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3 (2017) (1)
Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol-linkted proteins (2000) (1)
Dermatological adverse events associated with use of oral mechanistic target of rapamycin inhibitors in a cohort of individuals with tuberous sclerosis complex (2020) (1)
Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study (2021) (1)
Baseline Serum VEGF-D Levels Are Associated With Disease Severity And Treatment Response In Lymphangioleiomyomatosis (2011) (1)
Substrate specificity of soluble and membrane‐associated ADP‐ribosyltransferase ART2.1 (2006) (1)
Mono(ADP-Ribosylation) of Proteins at Arginine in Vivo (1985) (1)
Stimulation of Choleragen Enzymatic Activities by GTP and a Membrane Protein from Bovine Brain (1989) (1)
TSC1 and TSC2 Genotype in Tuberous Sclerosis Complex: Are Other Manifestations of this Multisystem Disease Affected by Genotype? (2021) (1)
LYMPHANGIOLEIOMYOMATOSIS : IMAGING FEATURES (1999) (1)
Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue (2021) (1)
A Mixed Blood-Lymphatic Endothelial Cell Phenotype in LAM and IPF but not in Kaposi's Sarcoma or TSC. (2022) (1)
The MILES Trial: Effect Of Menopausal Status On Disease Progression And Treatment Responses In Lymphangioleiomyomatosis (2012) (1)
Isolation, cloning, and characterization of brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factor. (2001) (1)
ADP-ribosylation factor, a guanine nucleotide-binding protein activator of cholera toxin, is isolated in an activated state when expressed as a fusion protein in Escherichia coli. (1992) (1)
ADP-Ribosylation of transducin subunits by pertussis toxin (1984) (1)
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers (2012) (1)
Molecular Mechanisms and Therapeutics of Skin Hamartomas in Tuberous Sclerosis Complex (2014) (1)
Identification of the probable site of choleragen-catalyzed ADP-ribosylation in a GoA-like protein based on cDNA sequence ( adenylate cyclase / cholera toxin / guanyl nucleotide-binding proteins / pertussis toxin / transducin ) (1)
Faculty Opinions recommendation of Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis. (2012) (1)
Molecular Characterization of ADP-Ribosylation Factors (1993) (1)
Activation of the NAD Glycohydrolase, NAD:Agmatine and NAD:Gsα ADP-Ribosyltransferase and Auto-ADP-Ribosylation Activities of Choleragen by Guanyl Nucleotide and Soluble Proteins Purified from Bovine Brain (1989) (1)
Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates (2023) (1)
Mechanism of Inhibition of Transducin Activity by Vanadate* Guanosine Triphosphatase (1988) (1)
Structural and biochemical analysis of human ADP-ribosyl-acceptor hydrolase 3 reveals the basis of metal selectivity and different roles for the two magnesium ions (2021) (1)
G Proteins and Toxin-Catalyzed ADP-Ribosylation (1990) (1)
Multicenter International Lymphangioleiomyomatosis Efficacy And Safety Of Sirolimus (MILES) Trial (2011) (1)
Effects of BIG1 and KANK1 on cell polarity and directed migration during wound healing (2011) (0)
Addressing the challenges of lymphangioleiomyomatosis assessment in the clinic (2017) (0)
257 Cutaneous tumors in tuberous sclerosis complex correlate with pulmonary disease severity (2018) (0)
Irish thoracic society (1998) (0)
ADP-ribose-acceptor hydrolase 2 (Arh2) deficiency results in cardiac dysfunction, tumorigenesis, inflammation, and decreased survival (2023) (0)
Red Clover (Trifolium pratense) = Nancy L. Booth and Colleen E. Piersen (2004) (0)
Faculty Opinions recommendation of Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. (2008) (0)
Lysyl hydroxylase 2 deficiency promotes filopodia formation and fibroblast migration. (2021) (0)
Effect of mild temperature shift up on poly(ADP-ribose) and gamma-H2AX levels in cultured cells (2016) (0)
BIG1 and BIG2: Brefeldin A-Inhibited Exchange Factors for Arfs (2004) (0)
Stability of ADP-ribose ( Arginine ) Protein 6467 (2001) (0)
Activation of Cholera Toxin and E. Coli Heat-Labile Enterotoxin (LT) by Arf (2004) (0)
Mounier-Kuhn Syndrome Mimicking Lymphangioleiomyomatosis. (2018) (0)
Mono-ADP-ribosyltransferase 1 (Artc1)-deficiency decreases tumorigenesis, increases inflammation, decreases cardiac contractility, and reduces survival (2023) (0)
ROLE OF LUNG TRANSPLANTATION IN THE MANAGEMENT OF PATIENTS WITH LAM: BASELINE DATA FROM THE NIH LAM REGISTRY (2005) (0)
Selective Association with Golgi of ADP-Ribosylation Factors, 20-kDa Guanine Nucleotide-Binding Protein Activators of Cholera Toxin (1993) (0)
Kava (Piper methysticum) = Steven M. Musser (2004) (0)
TSA-inspired micro tomosythesis scanner for rapid scouting of histopathology samples. (2020) (0)
Hydroxytryptophan = Pedro Del Corral and Karel Pacak (2004) (0)
Isoflavones = Mark Messina (2004) (0)
TRIM23 mediates virus-induced autophagy via activation of TBK1 (2017) (0)
The Physiological Basis for the Scavenging of Oxygen and its Radicals in Heterocysts of the Cyanobacterium Nostoc muscorum (1984) (0)
Brefeldin A-inhibited guanine ni Sec7 domain from yeast Sec7 wi' ribosylation factors (1998) (0)
Regulation of immune function by adp-ribosylation: Il-2-mediated induction in human nk cells of an nad:arginine adpribosyltransferase (1996) (0)
Grape Seed Extract = Dallas L. Clouatre and Chithan Kandaswami (2004) (0)
Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase (2017) (0)
Chapter 6 BIG 1 AND BIG 2 : BREFELDIN A-INHIBITED EXCHANGE FACTORS FOR ARFS Actions of brefeldin (0)
Ankyrine-Rich TRP Channel, ANKTM1, TRPA1 (2012) (0)
Ginger (Zingiber officinale) = Tieraona Low Dog (2004) (0)
Bronchoalveolar Lavage And Transbronchial Lung Biopsy In Langerhans Cell Histiocytosis And Lymphangioleiomyomatosis (2011) (0)
Atrial Natriuretic Factor Suppresses cAMP Content of Human Fibroblasts Independent of the Inhibitory Guanyl Nucleotide-Binding Regulatory Component of Adenylate Cyclase (1986) (0)
Combined Benefits of a PAR2 Inhibitor and Stratum Corneum Acidification for Murine (2016) (0)
Monoclonal antibodies which require amine-terminal acylation of transducin for immunoreactivity differ functionally in effects on beta-dependent reactions (1993) (0)
162 CXCL12 is a potential paracrine factor in tuberous sclerosis tumorigenesis (2018) (0)
New perspectives on virus-host cell receptor interactions as observed with sendai virus (1985) (0)
Characterization of NAD: arginine ADP-ribosyltransferases in animal tissues. (1983) (0)
ADP-Ribosylation of transducin and inhibition of GTPase activity by turkey erythrocyte NAD: Arginine ADP-ribosyltransferase (1984) (0)
Systemic And Autocrine Effects Of Osteoprotegerin On Clinical Phenotypes And Cell Biology In Lymphangioleiomyomatosis (2012) (0)
Mechanism of inhibition of Shiga-toxigenic Escherichia coli SubAB cytotoxicity by steroids and diacylglycerol analogues (2018) (0)
In Vitro ADP-Ribosylation Utilizing 2′Deoxy-NAD+ as a Substrate (1989) (0)
Mesenchymal cell specific deletion of Tsc2 regulates hair follicle development and patterning (2016) (0)
Biotin = Donald M. Mock (2004) (0)
Role of ADP‐ribosylation factor domain protein 1 (ARD1/TRIM23) on lysosome biogenesis and function (2012) (0)
Cruising the Villus-to-Crypt Axis: The Role of Cyclic 3*,5*- Guanosine Monophosphate in Duodenal Bicarbonate (1996) (0)
Methacholine reactivity in lymphangioleiomyomatosis is inversely related to FEV1 and VEGF-D (2021) (0)
Critical Role for NAD Glycohydrolase in Regulation of Erythropoiesis by Hematopoietic Stem Cells through Control of Intracellular NAD Content* (2014) (0)
O-Acetyl-ADP-ribose Isomers as Substrates for ARH (2011) (0)
Signal transduction by guanine nucleotide-binding proteins: possible molecular basis for multiple forms of Go alpha mRNA. (1988) (0)
Amino Acid-Specific ADP-Ribosylation: Purification and Properties of an Erythrocyte ADP-Ribosylarginine Hydrolase (1989) (0)
An Enzyme-Linked Immunosorbent Assay to Quantify Poly (ADP-Ribose) Level In Vivo. (2023) (0)
THE EXPRESSION OF CD4 AND CD64 RECEPTORS ON THE SURFACE OF HUMAN SPERMATOZOA AND THEIR RELATIONSHIP TO HIV TRANSMISSION (1994) (0)
Omega-3 Fatty Acids = William S. Harris (2004) (0)
Ginseng, American (Panax quinquefolium) = Thomas S.C. Li (2004) (0)
Preparation and assay of recombinant ADP-ribosylation factor-like protein-1 (ARL1). (2001) (0)
Riboflavin = Richard S. Rivlin (2004) (0)
Reply: The ATS/JRS Guidelines on Lymphangioleiomyomatosis: Filling in the Gaps. (2017) (0)
Coupling of receptors to signal transducing components: use of anti-idiotypic antibodies to map the specific sites of interaction of receptors and guanyl nucleotide-binding proteins. (1985) (0)
STRUCTURE AND FUNCTION OF RAS SUPERFAMILY SMALL GTPASES (1999) (0)
Zinc = Carolyn S. Chung and Janet C. King (2004) (0)
Milk Thistle (Silybum marianum) = Elena Ladas, David J. Kroll, and Kara M. Kelly (2004) (0)
Of ﬁ cial American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management (2016) (0)
Should lymphangioleiomyomatosis patients be permitted to donate blood? (2016) (0)
MECHANISM AND REGULATION OF ACETYL CoA CARBOXYLATION: INTERSUBUNIT TRANSLOCATION OF THE BIOTIN PROSTHETIC GROUP* (1972) (0)
Computer-aided Grading Of Lymphangioleiomyomatosis And Pathological Examination Detect Lung Tissue Abnormalities In Areas Adjacent To Cysts That Correlate With Lung Function (2010) (0)
Selective Expression of RT6 Superfamily in Human (1999) (0)
Abstract 1576: Mesenchymal disruption of Tsc2 in mice results in highly vascular hamartomas. (2013) (0)
Matrilysin/MMP-7 Expression in Lymphangioleiomyomatosis (LAM). (2009) (0)
Faculty Opinions recommendation of Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study. (2017) (0)
Abstract 2501: Rapamycin inhibits epidermal cell proliferation in a xenograft model of tuberous sclerosis skin tumors (2010) (0)
Abstract 2469: Increased cathepsin B expression in cultured tuberous sclerosis skin tumor cells and patient tumor tissues (2012) (0)
Ephedra (Ma Huang) = Anne L. Thurn (2004) (0)
surfactant protein B gene influences transcription and protein levels of 18) polymorphism in the surfactant protein B (2016) (0)
Differential interaction ofADP-ribosylation factors 1,3,and5with ratbrain Golgi membranes (cholera toin/protein trafcklng/endoplasmic refIculum/vescular transport) (1992) (0)
790 Tsc2 haploinsufficiency accelerates tumor progression in a mouse model of TSC skin tumors (2018) (0)
ARH3 catalyzes degradation of mitochondrial matrixaccumulated Poly (ADP‐ribose) (2012) (0)
Pathophysiology of Lymphangioleiomyomatosis (2021) (0)
ADP-ribosylation Factors: ARF Structure and Function (1995) (0)
Vitamin K = J.W. Suttie (2004) (0)
286. PARALYTIC EFFECT OF TETANUS TOXIN AND COMPLEXES OF THE TOXIN AND SPECIFIC ANTI (1986) (0)
Arf guanine nucleotide‐exchange factors BIG1 and BIG2 regulate β‐catenin signaling via direct interaction and cAMP/PKA pathway (604.1) (2014) (0)
Mutation Subjects With the Same Telomerase Natural History of Pulmonary Fibrosis in Two (2011) (0)
Title Helicobacter pylori VacA toxin causes cell death by inducing accumulationof cytoplasmic connexin 43 (2017) (0)
Characterization of Class I 1 and Class I 11 ADP-ribosylation Factor Genes and Proteins in Drosophila melanogas # er * (2001) (0)
367 Cutaneous features and variant allele fraction correlate with disease severity in mosaic tuberous sclerosis complex (2019) (0)
362 Necklace sign as a marker of pulmonary disease severity in tuberous sclerosis complex (2019) (0)
Effects of ADP‐ribosylarginine Hydrolase (ARH1) on Cell Proliferation and Tumorigenesis (2009) (0)
The lung microbiome in end-stage Lymphangioleiomyomatosis (2021) (0)
Vitamin E = Maret G. Traber (2004) (0)
Reply: Characterization of lymphangioleiomyomatosis as a neoplastic disease. (2013) (0)
Faculty Opinions recommendation of Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM). (2012) (0)
Reply to "Renal Lesions in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex Are Rarely Biologically Aggressive". (2018) (0)
Solubilization of a guanyl nucleotide-sensitive alpha/sub 1/ adrenergic receptor from liver membranes (1987) (0)
Effect of 8‐Bromo‐cAMP on accumulation of brefeldin A‐inhibited guanine nucleotide‐exchange protein 1 (BIG1) in the HepG2 cell nucleus (2006) (0)
Green Tea Polyphenols = Shengmin Sang, Joshua D. Lambert, Chi-Tang Ho, and Chung S. Yang (2004) (0)
Enzyme nad:arginine adp-ribosyltransferase des muscles de mammiferes (1993) (0)
Faculty Opinions recommendation of Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax. (2007) (0)
517 Disseminated disease despite low mutant allele fractions: The variable phenotype of mosaic tuberous sclerosis complex (2017) (0)
INHIBITION OF IMIDAZOLEACETATE PHOSPHORIBOSYL TRANSFERASE (1976) (0)
MOLECULAR CHARACTERIZATION OF ADP-RIBOSYLARGININE HYDROLASES AND MONO-ADP-RIBOSYLTRANSFERASES (ARTs) (2001) (0)
Abstract 5510: Tranilast inhibits growth of skin tumor cells in a xenograft mouse model of tuberous sclerosis complex. (2013) (0)
Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Haras-encoded p 21 ( liposomes / adenylate cyclase / guanine nucleotide-binding protein / oncogene / transducin ) (0)
Purine Receptor Lineage-SpecificHuman NK Cells Through a Purine Metabolites Suppress Proliferation of Okazaki and (1999) (0)
Multiple cytosolic forms of hepatic beta-hydroxy-beta-methyglutaryl CoA synthase: possible regulatory role in cholesterol synthesis. (1972) (0)
A method for suppressing an immune response or for treatment of proliferative diseases (2004) (0)
Biochemical and Developmental Characterization of ADP-ribosylation Factors, A Family of 20 kDa Guanine Nucleotide-binding Proteins. (1992) (0)
1 cAMP-dependent PKA Signaling Induces TNFR 1 Exosome-like Vesicle Release via Anchoring of PKA Regulatory Subunit RII β to BIG 2 (2008) (0)
Modification of proteins in intact cells by choleragen (1980) (0)
Adenylyl Cyclase Inhibitory Gi Alpha Subunit (2012) (0)
guanine nucleotide-exchange protein, ARF-GEP, apoptosis, phagocyte Mini Review グアニンヌクレオチド交換タンパク質(guanine nucleotide-exchange protein; GEP)によるマク (2006) (0)
Molecular cloning of complementary dna for human go alpha (1987) (0)
Prostaglandin E modulation of fibroblast fibronectin production: An interaction between inflammatory cells and the production of connective tissue matrix (1982) (0)
Mediators of inflammation and collagen synthesis kinins decrease collagen production by human fibroblasts (1982) (0)
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Vacuolating Cytotoxin-Induced Autophagy and Apoptosis During Helicobacter pylori Infection (2016) (0)
Auto‐ADP‐ribosylation inhibits the catalytic activity of ExoS, a type‐III effector of Pseudomonas aeruginosa (2006) (0)
Brefeldin A‐inhibited guanine nucleotide‐exchange protein 1 (BIG1) associates with nucleolin and U3 snoRNA in HepG2 cell nuclei (2008) (0)
376 Tsc2 disruption in mesenchymal progenitors regulates hair follicles and TGF beta signaling (2019) (0)
Exercise-induced haemoptysis as a rare presentation of a rare lung disease (2016) (0)
S1 New Insights into the Pathogenesis of Bacterial Diseases (2009) (0)
Phosphorus = John J.B. Anderson and Sanford C. Garner (2004) (0)
INTERSTITIAL LUNG DISEASE | Lymphangioleiomyomatosis (2006) (0)
064 Genome analysis reveals UV signature mutations in sun-exposed skin tumors in tuberous sclerosis complex (2021) (0)
258 Mosaicism in tuberous sclerosis complex detected by genome analysis (2020) (0)
cytohesin-1 and regulates its (2016) (0)
Melatonin = Richard J. Wurtman (2004) (0)
Isolation, characterization and immunological properties of bovine liver adenosine kinase (1987) (0)
Hair graying may occur early in life in tuberous sclerosis complex and is distinct from poliosis. (2020) (0)
BIG2, an ARF guanine nucleotide‐exchange protein, regulates cell migration via effects integrin β1 cycling and actin cytoskeleton remodeling (2012) (0)
Vitamin B6 = James E. Leklem (2004) (0)
CORRESPONDENCE (1992) (0)
Bacterial Toxins and Diarrhea (2003) (0)
A novel endoplasmic stress mediator, Kelch domain containing 7B (KLHDC7B), increased Harakiri (HRK) in the SubAB-induced apoptosis signaling pathway (2021) (0)
LOCALIZATION AND EXPRESSION OF HUMAN TRACHEAL GLYCOSYLPHOSPHATIDYLINOSITOL(GPI)-ANCHORED ADP-RIBOSYLTRANSFERASE (1997) (0)
401 Dermal fibroblasts with loss of TSC2 express increased galectin-3, a potential biomarker for tuberous sclerosis complex (2016) (0)
Faculty of 1000 evaluation for Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study. (2018) (0)
Acetyl Coenzyme A Carboxylase IV . BIOTINYL PROSTHETIC (2002) (0)
Aquilion ONE Clinical Evidence: Low Dose (2019) (0)
La localización celular de la proteína ARD1/TRIM23 depende de su actividad de E3 ubiquitina ligasa (2014) (0)
Abnormal Lymphangiogenesis in Idiopathic Pulmonary Fibrosis: Insights into Cellular and Molecular Mechanisms. (2009) (0)
Distribution of G/sub o. cap alpha. / mRNA and protein in bovine tissues (1987) (0)
TISSUE-SPECIFIC EXPRESSION AND CELLULAR LOCALIZATION OF GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED NAD:ARGININE ADP-RIBOSYLTRANSFERASE. (1996) (0)
ETV2 regulates PARP-1 binding protein to induce ER stress-mediated cell death in tuberin-deficient cells (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Joel Moss?

Joel Moss is affiliated with the following schools:

Joel Moss's Academic­Influence.com Rankings

Joel Moss's Degrees

Why Is Joel Moss Influential?

Joel Moss's Published Works

Published Works

What Schools Are Affiliated With Joel Moss?

Joel Moss's AcademicInfluence.com Rankings